HEPATITIS C
Clinical trials for HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C trials appear
Sign up with your email to follow new studies for HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study uses tele-health to bring HIV and hepatitis c treatment to drug users
Disease control OngoingThis study compares two methods of offering HIV, hepatitis C, and addiction medications to 100 people who inject drugs. Participants are already part of syringe service programs in Miami and Tampa. The goal is to see which method helps more people achieve HIV viral suppression an…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Second chance for hepatitis c patients: which treatment works best?
Disease control ENROLLING_BY_INVITATIONThis study is for people in Pakistan with hepatitis C whose first treatment didn't work. It compares two different drug combinations to see which one clears the virus better. About 318 adults will take part, and the goal is to find the safest and most effective second-line option…
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
Hearts from hepatitis c donors could expand transplant options for patients in need
Disease control OngoingThis study tests whether hearts from donors with hepatitis C can be safely given to people without hepatitis C who need a heart transplant. Twenty adults with end-stage heart failure on the transplant waiting list will receive such hearts and be treated with antiviral medication …
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Mary E. Keebler, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could hepatitis c positive lungs be safely transplanted into negative patients?
Disease control OngoingThis study explores whether lungs from donors with hepatitis C can be safely given to recipients without the virus. The lungs are treated with a special machine (EVLP) to try to reduce the virus, and if infection occurs, standard antiviral drugs are used. The goal is to see if th…
Matched conditions: HEPATITIS C
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Transplant breakthrough: hepatitis c kidneys safely used for healthy patients
Disease control OngoingThis study tests whether kidneys from donors with hepatitis C can be safely transplanted into patients without the virus. After transplant, patients receive an antiviral drug to prevent infection. The goal is to expand the donor pool and reduce wait times for kidney transplants.
Matched conditions: HEPATITIS C
Phase: PHASE2 • Sponsor: Amit D Tevar, MD • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC
-
Breakthrough drug combo may stop hepatitis c spread in organ transplants
Prevention OngoingThis study tests whether a short course of two drugs (glecaprevir/pibrentasvir and ezetimibe) can prevent hepatitis C infection in people who receive a kidney, heart, lung, or pancreas from a hepatitis C-positive donor. About 200 participants who are hepatitis C-negative and awai…
Matched conditions: HEPATITIS C
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated May 11, 2026 20:38 UTC
-
Peer support aims to boost hepatitis c treatment after prison
Knowledge-focused OngoingThis study tests a program where trained peers help people recently released from jail or prison get connected to Hepatitis C care and stay in treatment. About 80 adults with chronic Hepatitis C who were incarcerated in the U.S. will take part. The goal is to see if this support …
Matched conditions: HEPATITIS C
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC